Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Models for treating depression in specialty medical settings: a narrative review.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Objective and subjective measures reflect different aspects of balance in multiple sclerosis.
Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Etiologic exploration of magnetic resonance tomographic angiography negative trigeminal neuralgia.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.
Exome sequencing identifies a novel, multiple sclerosis susceptibility variant in the TYK2 gene.
The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
[Update on diagnosis and treatment of multiple sclerosis.]
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Regulation: The FDA is overcautious on consumer genomics.
TREK-King the Blood-Brain-Barrier.
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis.
Substance Name: Simvastatin
Dendritic Cells and Anergic Type I NKT Cells Play a Crucial Role in Sulfatide-Mediated Immune Regulation in Experimental Autoimmune Encephalomyelitis.

Pages